Draceana cinnabari (Dracaenaceae) is traditionally used in the treatment of wounds, leucorrhea, fractures, and diarrhoea. Herein, we performed a pre-clinical safety evaluation of extract of Draceana cinnabari resin on Spradgue Dawley rats. Toxicological codicil of the extract was carried out following OECD guidelines 423 and 407, with minor changes. DC resin methanol extract administered to the rats by oral gavage at 50, 500, 1500, and 2500 mg/kg body weight daily up to 28 days to male and female rats. Herbal extract could most likely be very much endured up to the dose 2000 mg/kg body weight and could be named Category 4. Oral toxicity studies confirm that Draceana cinnabari has no therapy-related demise or toxic signs on rats. Therefore, the resin, ought to be suitably considered for additional research for its medicinal and therapeutic efficacy.
INTRODUCTION
Medicinal plants, either as an extract, pure compound, or as a derivative, offer unlimited opportunities for the discovery of new drugs. Most of the natural products used in folk remedy have solid scientific evidence about their biological activities. However, there is little information or evidence available concerning the possible toxicity that medicinal plants may cause to consumers 1 . Toxicity is a terminology used to describe the property of being poisonous or indicate the state of detrimental outcomes by means of the interaction between toxicants and cells. This mechanism of action may likewise change depending on the cell membrane and chemical residences of the toxicants. It may occur inside the cell membrane or on the cell surface or tissue beneath as well as at the extracellular matrix. In most of the occurrence, visceral organs such as liver, lung and kidney are affected via the toxicants 2 .
Many studies have already shown that several medicinal plants have detrimental effects. The customary use of any plant for the ameliorative outcome, itself does not guarantee the safety of that plant. Thus, data of the acute and subchronic toxicity studies on medicinal plants or their preparations should be obtained to increase the confidence in their safety to humans, particularly for use in the development of pharmaceuticals 3 .
Dragon's blood is a name applied to resins obtained from plants like Dracaena Pharmacological investigations indicate that it can inhibit the aggregation of platelets, venous thrombosis and bacterial action. It additionally has anti-inflammatory, analgesic and homeostatic effect. 6, 7 Recently, Dracaena has been clinically used for treatment of cerebral arterial thrombosis, ischemic heart disease and peptic ulcer 8 . However, not much work has been done of its safety profile by toxicity studies The purpose of this work is to explore the acute and chronic toxicity profile along with the antioxidant properties of D. cinnabari resin extract.
MATERIALS AND METHODS

Plant material
Dracaena cinnabari resin used in this study was procured from the local bazaar Ballimaran, Delhi, India. A voucher specimen (NISCAIR/RHMD/Consult/2008-09/1192/224) of the resin was collected, identified and deposited at NISCAIR, New Delhi, India
Chemical reagents
All the chemicals used in this study were obtained from HiMedia Laboratories Pvt. Ltd. (Mumbai, India), Sigma-Aldrich Chemical Co. (Milwaukee, WI, USA), and SD Fine-Chem. Ltd.
(Mumbai, India). All the chemicals used in this study were of analytical grade.
Preparation of plant extracts
The crude extracts were prepared by cold maceration technique 9 . The extraction was done by refluxing 300 g of resin in 2400ml of methanol (98%) and placing the mixture on an orbital shaker (at 160rpm) for 72 hrs. The mixture was concentrated in a rotary evaporator. The resulting extract (DRE) was lyophilised and stored in an amber coloured airtight container at 4°C until further use.
Selection and Procurement of animals
Experimental animals
For acute and subacute oral toxicology assessment, (total of 65), age (6 weeks) and weight (129.1 to 140.2 gm) matched female and male Sprague Dawley (SD) pathogen-free rats were used. Fifteen female rats were used for an acute oral toxicity test; furthermore forty rats (twenty-five males and twenty-five females) were used for acute oral toxicity tests (twenty-eight days of recurrent dose). The toxicity tests were carried out according to Organization for Economic Cooperation and Development (OECD) test guideline, specifically OECD Guideline 423 for the acute oral toxicity test 10 and OECD Guideline 407 for the sub-acute oral toxicity test 11 with slight modifications. All animals were procured and housed in animal house maintained under standard hygienic conditions. Animals were acclimatised to the laboratory environment for seven days ahead of the experiments. The animals were allowed free to access commercial rat pellet diet (Lipton India Ltd, Mumbai, India) and water ad libitum. The bedding materials of the enclosure were changed every day. All the experimental trial was carried out in conformity with the CPCSEA guidelines. 
Acute toxicity
Animals were randomly divided in the group (n=3), a control group (Group A) and dose levels (Groups A1, A2, A3 and A4, administered respectively 50mg, 500mg, 1500mg and 2500 mg DRE / kg body weight). DRE was given once by oral gavage at a weight of 10 mL/kg body weight. The control animals have been treated with distilled water in the same volume. Animals were observed for three hours after dose administration changes in behaviour. The rats were weighed, and visual observations for mortality, behavioural pattern (salivation, fur, lethargy, and sleep), changes in physical appearance, injury, pain, and any signs of illness were conducted once daily during of 24 and 48 hours.
Sub-chronic Toxicity
The remaining forty male and female SD rats (n = 5 males and 5 females/group) were arbitrarily divided into a control (Group SC) and three dose teams (GroupSC1, SC2, SC3, and SC4 administered fifty, five hundred, fifteen hundred and twenty-five hundred mg/kg body weight/day, respectively). The standard procedures were followed as per the OECD 407 guidelines (OECD, 143 2008). DRE was administered once daily for four weeks, by oral gavage of 10 mL/kg body weight. Control animals have only been, treated with the same quantity of distilled water during the four weeks assay period.
The dosage was freshly prepared on a day to day basis. The rodents were weighed. Rats observed visually for morbidity, changes in behaviour ( like dormancy, fur, rest and salivation), changes in physical appearance, damage, agony and malady were done once a day during that period. Animals were fasted overnight at the end of the treatment, albeit with water ad libitum. Blood samples were collected thru retro-orbital puncture employing capillary tubes for haematological and biochemical research along with anticoagulant EDTA. All rats were anaesthetised with isoflurane and afterwards sacrificed through exsanguinations from carotid and jugular vessels. 12 Complete postmortem examination was carried out on all animals.
Analogous organ weight determination:
Organs, that is liver and kidneys were meticulously eviscerated from the rats immediately after sacrifice and weighed in grams. The comparative organ weight of each animal was then quantified as follows:
Relative organ weight = absolute organ weight (g) × 100/ body weight of rat on sacrifice day (g)
Haematology and serum biochemistry:
Haematological and biochemical studies of liver function, plasma constituents, and electrolyte concentrations were determined using standard clinical procedures.
Haematological parameters
For complete blood count, 3.0 ml of venous blood was taken in a vacutainer tube containing EDTA as an anticoagulant. Basic haematological estimated were haemoglobin (Hb) content, red blood cell (RBC), total white blood count (WBC), and differential WBC count (neutrophil, eosinophil, basophil, lymphocyte and monocyte), as well as platelet count, were performed using an automated analyzer Automatic Hemato analyzer (MS-4) (Melet Schloesing Laboratories, Osny, France)). 13 Serum biochemical parameters, which were measured from serum using kits (Span Diagnostic Ltd., Surat, Gujarat, India using a UV-VIS Spectrophotometer (Shimadzu, Tokyo, Japan). Serum biochemical parameters included total serum protein (TP), creatinine (CREA), blood urea nitrogen (BUN), albumin (ALB), alkaline phosphatase (ALP), glutamate oxaloacetate transaminase (GOT), and glutamate pyruvate transaminase(GPT) 14 .
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Histopathology
Organs were fixed and preserved in 10% phosphate-buffered formalin. Tissues were fixed by embedding in paraffin, sectioned, and stained with hematoxylin and eosin. Collected tissues were grossly and microscopically examined 15 .
Statistical analysis
The results were expressed as mean ± SEM (n = 5). Data acquired as of hematology analysis, serum biochemistry, as well as the body and organ weight measurements were articulated as mean + SD and evaluated by unpaired t test (2-tailed P value) to compare the mean of the treated group of each sex with the control.Data were analysed using Student's t-test, and results were considered significant when p < 0.05. ALB, albumin; ALP, alkaline phosphatase; ALT, ala-nine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; CREA, creatinine; TP, total protein; Table 6 Hematological s data of male SD rats treated orally with DRE for 4 weeks (n = 5) Table 7 : Serum biochemical data of male SD rats treated orally with DRE for 4 weeks (n = 5) ALB, albumin; ALP, alkaline phosphatase; ALT, ala-nine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; CREA, creatinine; TP, total protein;
RESULTS
Acute Toxicological Studies
In the present investigation, we assessed the likely toxicity and 50% lethal dose (LD50) of DRE following a regiment of solitary oral to female rodents. DRE was orally administered once at doses of 50mg, 500mg, 1500mg and 2500 mg DRE / kg body weight to SD rats. Mortality, clinical signs, and body weight changes were observed for 120 hours days after administration. No deaths in any animals were observed during the experimental period. No test substance-related effects were evident concerning clinical signs, body weight changes, and necropsy findings at all dosages as shown in Table 1 . These results suggest that acute exposure to DRE does not cause toxic effects, and its LD50 value is considered to be greater than 2500 mg/kg in rats. 
Sub-chronic Toxicological Studies
No toxicity signs (such as piloerection, alteration in the locomotor activity or food and water consumption) or deaths were recorded during the 28 consecutive days of treatment by oral route with D. cinnabari resin extract in doses fifty, five hundred, fifteen hundred and twenty-five hundred mg/kg body weight/day, respectively). As expected, the rat's body weight increased with time. Equally, no significant changes were recorded in body weight gain of control and treated rats (Table 2 and 3) . However, the rats treated with DRE did present mild diarrhoea at some point in the period of treatment, portentous of a laxative effect of the extract. The treatment with a hydro-alcoholic extract of D. cinnabari for 28 days did not alter the biochemical profile of female and male S D rats, as shown in Tables 5 and 7 , respectively.
Haematological analysis
In the same way, the haematological profile of female (Table  4 ) and male rats (Table 6) was not altered by treatment with DRE. In both biochemical and haematological studies, all values in control and treated groups were within the reference range for the species.
DISCUSSION
Herbal medicines are used worldwide for the treatment and prevention of various acute and chronic diseases and are gaining popularity in developing countries. Herbal medicines are often believed to be harmless because they are "natural" and are easily available and commonly used for selfmedication without supervision. These medicines contain 7bioactive constituents with potential to cause adverse effects. 16, 17 . The results of the present study suggested that D. cinnabari is a relatively nontoxic plant. During 120 hours period of acute toxicity evaluation, rats were not associated with any mortalities and abnormalities in general conditions, behavior and growth, feed and water consumption of animals. Body weight changes are indicators of adverse side effects, as the animals that survive cannot lose more than 10% of the initial body weight 18 . Body weight gain and feed consumption levels were similar in both control and treated animals.
ALP, ALT, AST in tissue and blood are important marker enzymes which are used to assess the integrity of the cell membrane, cytosolic activity and cell death 19 . The extent of hepatocellular injury is assessed by the increased serum levels of ALP, ALT, and AST .The study results indicate that the value of marker enzymes was within normal permissible limits and same was observed in case of various hemaetological parameters.
CONCLUSION
In conclusion, the DRE was well tolerated, lack of mortality and neither produced overt signs of clinical toxicity ( loss of hair, behavioral changes, impairments in feed intake and body weight gain), nor any signs of hepato-, nephro-, or haematotoxicity, also well supported by biochemical data. This acute toxicity study suggests that the extract of D. cinnabari resin is safe up to the dose of 2500mg/ kg b.w. especially when consumed by oral route. Further studies in repeated doses (sub-acute and chronic) must be performed to prove its safety.
